Stephen DiMartino

Title: The Innovations of Stephen DiMartino

Introduction

Stephen DiMartino is an accomplished inventor based in Scarsdale, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of knee and hip pain. His innovative approach has led to the development of a unique pharmaceutical composition aimed at patients who are non-responsive or intolerant to standard analgesic therapies.

Latest Patents

Stephen DiMartino holds 1 patent for his work titled "Pharmaceutical composition for safe and effective treatment of knee and/or hip pain." This patent discloses a pharmaceutical composition and a method for treating knee and/or hip pain in patients who do not respond to conventional analgesics. Additionally, it outlines a method for reducing the risk of developing arthropathy in subjects receiving an anti-NGF antibody for the treatment of knee and/or hip pain. The patent also includes methods for monitoring the safety of treatments involving the administration of an anti-NGF antibody, particularly in patients with osteoarthritis of the knee and/or hip, where the anti-NGF antibody used is fasinumab.

Career Highlights

Stephen DiMartino is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Regeneron has positioned him as a key player in the pharmaceutical industry, focusing on innovative solutions for pain management.

Collaborations

Throughout his career, Stephen has collaborated with notable colleagues, including Gregory P Geba and Paula Dakin. These collaborations have further enriched his research and contributed to the success of his projects.

Conclusion

Stephen DiMartino's contributions to pharmaceutical innovation, particularly in pain management, highlight his dedication to improving patient outcomes. His patent and ongoing work at Regeneron Pharmaceuticals, Inc. reflect his commitment to advancing medical science.